Pro-Dex Inc. (PDEX): Earnings per share for the last twelve months

Brandmark of Pro-Dex Inc (PDEX)

Stable growth for Pro-Dex, Inc. (PDEX) is driven by conservative management and a debt-free balance sheet. The trailing 12-month net income per share confirms this trend, with 3.68 recorded as the baseline value. The humanitarian status of the industry and localized supply chains guarantee business security. High surgeon confidence in instrument precision solidifies the company's status as a leading developer in the medical field.

PDEX pro-dex.com Net earnings per share for the last four quarters (07/04/2022 - 11/10/2026)
Mass-produced product of Pro-Dex Inc.

Pro-Dex, Inc. (PDEX) is scaling the production of electrosurgical instruments through long-term OEM contracts with medtech giants. This metric recalculates the aggregate net income for a rolling year per common share. By analyzing this 12-month net income per share chart, an investor can see the real return on equity without seasonal fluctuations. The trajectory of the line reflects the efficiency of converting production capacities into profit. Growth in this metric confirms the fundamental undervaluation or fair value of the asset.

Competitor analysis

Intuitive Surgical - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters danaher.com DHR|Becton Dickinson (BDX) - Earnings per share for the last twelve months|Earnings per share for the last 12 months STE|Earnings per share for the last twelve months West Pharmaceutical Services Inc|Baxter Healthcare (BAX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months MASI (Masimo Corporation)|Earnings per share for the last four quarters STVN|Earnings per share for the last twelve months Teleflex TFX|Earnings per share for the trailing year MMSI|NVST: Net earnings per share for the last 12 months|ICUI - Net earnings per share (EPS TTM)|DENTSPLY SIRONA Inc. (XRAY) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months lemaitre.com|ATRC (AtriCure) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months STAAR Surgical Co. STAA|Earnings per share for the last twelve months Niagen (NAGE)|ZimVie Corp - Earnings per share for the last 12 months|AngioDynamics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CERS (cerus.com)|TKNO - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Monogram Technologies Inc. MGRM|sharpstechnology.com (STSS) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months INFU (InfuSystem Holdings, Inc.)|Earnings per share for the last twelve months Utah Medical Products|KRMD: Earnings per share for the trailing year|Earnings per share for the last twelve months Nyxoah (NYXH)|MBOT - Net earnings per one share for the last twelve months|Zentek Limited - Net earnings per share for the last 12 months|Net earnings per share for the trailing year Elutia Corporation|Milestone Scientific - Net earnings per share (EPS TTM)|NXGL (nexgel.com) - Earnings per share for the last 12 months|RVP: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months harvardbioscience.com (HBIO)|Net earnings per share for the last 12 months FEMY|Earnings per share for the last 12 months MHUA (Meihua Medical)|Net earnings per share for the last 12 months POAI (Predictive Oncology)|CJMB (callanjmb.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ATRI (Atrion)|Net earnings per share for the last four quarters NeuroMetrix Inc (NURO)